Ā 

Pervasis drug gets orphan status in Europe - Boston Globe PDF Print
Boston Globe
Pervasis Therapeutics Inc. said that the European Commission has granted orphan status to a company drug designed to help patients with end stage renal disease. The drug is Vascugel, and it aims to prevent hemodialysis vascular access failure in ...
Pervasis Receives Orphan Drug Designation in Europe for VascugelĀ® to Prevent

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.